S&P 500
(-0.88%) 4 967.23 points
Dow Jones
(0.56%) 37 986 points
Nasdaq
(-2.05%) 15 282 points
Oil
(0.63%) $83.25
Gas
(0.34%) $1.763
Gold
(0.21%) $2 403.00
Silver
(1.13%) $28.70
Platinum
(-1.15%) $943.50
USD/EUR
(-0.08%) $0.939
USD/NOK
(-0.22%) $11.02
USD/GBP
(0.54%) $0.808
USD/RUB
(-0.93%) $93.02

Realtime updates for Opthea Ltd [OPT.AX]

Exchange: ASX Industry: Pharmaceuticals, Biotechnology & Life Sciences
Last Updated19 Apr 2024 @ 02:10

1.59% $ 0.640

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 02:10):

Opthea Limited, a clinical stage biopharmaceutical company, develops and commercializes therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage...

Stats
Today's Volume 585 166
Average Volume 707 323
Market Cap 424.20M
EPS $0 ( 2024-02-27 )
Last Dividend $0.117 ( 2004-10-11 )
Next Dividend $0 ( N/A )
P/E -1.360
ATR14 $0.00100 (0.16%)

Volume Correlation

Long: -0.06 (neutral)
Short: -0.96 (very strong negative)
Signal:(62.535) Neutral

Opthea Ltd Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Opthea Ltd Correlation - Currency/Commodity

The country flag -0.30
( neutral )
The country flag 0.11
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag -0.34
( neutral )

Opthea Ltd Financials

Annual 2023
Revenue: $161 163
Gross Profit: $-89 309.00 (-55.42 %)
EPS: $-0.450
Q2 2023
Revenue: $93 181.00
Gross Profit: $14 798.00 (15.88 %)
EPS: $-0.250
Q4 2023
Revenue: $83 337.00
Gross Profit: $83 337.00 (100.00 %)
EPS: $-0.200
Q2 2023
Revenue: $77 793.00
Gross Profit: $77 793.00 (100.00 %)
EPS: $-0.230

Financial Reports:

No articles found.

Opthea Ltd Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Opthea Ltd Dividend Information - No Dividend Player

Dividend Sustainability Score: 0.0275 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future
Information
First Dividend $0.117 2004-10-11
Last Dividend $0.117 2004-10-11
Next Dividend $0 N/A
Payout Date 2004-11-01
Next Payout Date N/A
# dividends 1 --
Total Paid Out $0.117 --
Avg. Dividend % Per Year 0.00% --
Score 0.01 --
Div. Sustainability Score 0.0275
Div.Growth Potential Score 0
Div. Directional Score 0 --
Next Divdend (Est)
(2024-04-19)
$0 Estimate 0.00 %
Dividend Stability
0.00 Very Bad
Dividend Score
0.01
Pay Frequency
Insufficient data to determine frequency
Yearly Payout
Year Amount Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for ASX

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
WOW.AX Ex Dividend Junior 2023-08-31 Semi-Annually 0 0.00%
FAR.AX No Dividend Player 2023-08-23 Sporadic 0 0.00%
PIC.AX Ex Dividend Junior 2023-09-26 Semi-Annually 0 0.00%
APE.AX Ex Dividend Junior 2023-09-01 Annually 0 0.00%
HZN.AX Ex Dividend Knight 2023-10-17 Annually 0 0.00%
RMS.AX Ex Dividend Junior 2023-09-14 Sporadic 0 0.00%
CAJ.AX Ex Dividend Knight 2023-09-21 Semi-Annually 0 0.00%
LSF.AX Ex Dividend Knight 2023-09-11 Semi-Annually 0 0.00%
SXL.AX Ex Dividend Knight 2023-09-01 Annually 0 0.00%
CSR.AX Ex Dividend Knight 2023-05-26 Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-1 383.771.500-10.00-10.00[0 - 0.5]
returnOnAssetsTTM-1.4671.200-10.00-10.00[0 - 0.3]
returnOnEquityTTM8.771.50010.0010.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM5.100.80010.008.00[1 - 3]
quickRatioTTM5.000.80010.008.00[0.8 - 2.5]
cashRatioTTM4.821.50010.0010.00[0.2 - 2]
debtRatioTTM0.000780-1.5009.99-10.00[0 - 0.6]
interestCoverageTTM-8.081.000-4.10-4.10[3 - 30]
operatingCashFlowPerShareTTM-0.3062.00-0.102-0.204[0 - 30]
freeCashFlowPerShareTTM-0.3062.00-0.153-0.306[0 - 20]
debtEquityRatioTTM-0.00277-1.500-0.01110.0166[0 - 2.5]
grossProfitMarginTTM0.5561.0004.074.07[0.2 - 0.8]
operatingProfitMarginTTM-1 413.431.000-10.00-10.00[0.1 - 0.6]
cashFlowToDebtRatioTTM-1 397.121.000-10.00-10.00[0.2 - 2]
assetTurnoverTTM0.001060.800-3.33-2.66[0.5 - 2]
Total Score0.0275

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-1.7351.000-0.2760[1 - 100]
returnOnEquityTTM8.772.5010.0010.00[0.1 - 1.5]
freeCashFlowPerShareTTM-0.3062.00-0.102-0.306[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM-0.3062.00-0.102-0.204[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM0.01951.500-3.200[0.5 - 2]
operatingCashFlowSalesRatioTTM-1 027.631.000-10.000[0.1 - 0.5]
Total Score-0.549

Opthea Ltd

Opthea Limited, a clinical stage biopharmaceutical company, develops and commercializes therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. Its lead asset is OPT 302, a soluble form of VEGFR 3 in clinical development as a novel therapy for wet neovascular age related macular degeneration and diabetic macular edema (DME), as well as a first in class VEGF-C/D inhibitors for treatment with VEGF-A inhibitors to treat wet neovascular AMD and other retinal diseases. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited was incorporated in 1984 and is based in South Yarra, Australia.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators